Werner wrote: So, Nader is careful....why? To avo
Post# of 148184
(Total Views: 885)
Posted On: 03/23/2021 4:19:33 PM
Werner wrote:
So, Nader is careful....why? To avoid lawsuits when FDA says no? To protect the SP? We will soon find out...but i hope that Nader and the whole team have had enough discussions with the FDA concerning our EUA for Covid.When you file for an EUA at this stage, you have to be damn sure to get it...otherwise it is much better to file nothing!!!
my response:
That is the most valuable comment we can derive from the CC yesterday. That is why I bought more CYDY today.
Listen, when the m/m trial was done, Nader "discussed" the data with the FDA, rather than just applying for an EUA, then, he decided not to apply. When the s/c trial was done, again, he "discussed" the data with the FDA (and...with Amarex) and then, made a decision, to yes, apply for an EUA. The implication? A good chance of approval. The nation needs LL, the FDA know this. LL works, but for who? For just the sick? No, for those who are dying!!! Nothing is really helping them, LL will save between 240 and 320 of the 1000 American critical cv19 who are dying everyday. Now to put on my accountability hat, yes, that last statement is kind of based on only 62 patients in our s/c trial, but let's add our 2020 eIND results, and consider our m/m results, and consider our pristine safety results from m/m and s/c and HIV and misc doctor and Dr Pattersons experiences and papers.
What is available now to save the critical?
So, Nader is careful....why? To avoid lawsuits when FDA says no? To protect the SP? We will soon find out...but i hope that Nader and the whole team have had enough discussions with the FDA concerning our EUA for Covid.When you file for an EUA at this stage, you have to be damn sure to get it...otherwise it is much better to file nothing!!!
my response:
That is the most valuable comment we can derive from the CC yesterday. That is why I bought more CYDY today.
Listen, when the m/m trial was done, Nader "discussed" the data with the FDA, rather than just applying for an EUA, then, he decided not to apply. When the s/c trial was done, again, he "discussed" the data with the FDA (and...with Amarex) and then, made a decision, to yes, apply for an EUA. The implication? A good chance of approval. The nation needs LL, the FDA know this. LL works, but for who? For just the sick? No, for those who are dying!!! Nothing is really helping them, LL will save between 240 and 320 of the 1000 American critical cv19 who are dying everyday. Now to put on my accountability hat, yes, that last statement is kind of based on only 62 patients in our s/c trial, but let's add our 2020 eIND results, and consider our m/m results, and consider our pristine safety results from m/m and s/c and HIV and misc doctor and Dr Pattersons experiences and papers.
What is available now to save the critical?
(12)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼